ARRIVENT BIOPHARMA INC
AVBPNASDAQ🏆 #2067 by market capUS Equity
$31.25▼ $0.14 (−0.45%)
Live1h▼ 0.2%
24h▼ 0.5%
7d▲ 2.3%
14d▲ 4.1%
30d▼ 7.2%
1y▲ 84.5%
🏦Market Cap
$1.46B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
57
Weak
Earnings
Q2 · 2026Reported 2026-05-11Earnings Per Share
Actual
-0.96
Expected
-0.88
miss
−9.10%
YoY +49.50%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
-0.96
miss
Q1 2026
-0.78
beat
Q4 2025
-0.83
miss
Q3 2025
-0.90
miss